Lineage Cell Therapeutics
LCTX
#7572
Rank
โ‚ฌ0.34 B
Marketcap
1,49ย โ‚ฌ
Share price
14.29%
Change (1 day)
122.57%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -โ‚ฌ18.35 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ10.81 Million. In 2024 the company made an earning of -โ‚ฌ18.15 Million, an increase over its 2023 earnings that were of -โ‚ฌ20.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ18.35 Million1.07%
2024 -โ‚ฌ18.15 Million-13.16%
2023 -โ‚ฌ20.9 Million9.83%
2022 -โ‚ฌ19.03 Million-54.24%
2021 -โ‚ฌ41.58 Million86.07%
2020 -โ‚ฌ22.35 Million-31.97%
2019 -โ‚ฌ32.85 Million-5.42%
2018 -โ‚ฌ34.73 Million1.1%
2017 -โ‚ฌ34.36 Million-31.06%
2016 -โ‚ฌ49.83 Million-10.38%
2015 -โ‚ฌ55.6 Million29.69%
2014 -โ‚ฌ42.87 Million31.68%
2013 -โ‚ฌ32.56 Million
2011 -โ‚ฌ15.8 Million89.78%
2010 -โ‚ฌ8.33 Million206.06%
2009 -โ‚ฌ2.73 Million-0.58%
2008 -โ‚ฌ2.74 Million164.89%
2007 -โ‚ฌ1.04 Million-30.22%
2006 -โ‚ฌ1.49 Million
2002 -โ‚ฌ1.72 Million-41.04%
2001 -โ‚ฌ2.92 Million-32.04%
2000 -โ‚ฌ4.29 Million-11.85%
1999 -โ‚ฌ4.87 Million
1997 -โ‚ฌ3.13 Million12.12%
1996 -โ‚ฌ2.79 Million106.25%
1995 -โ‚ฌ1.36 Million-11.11%
1994 -โ‚ฌ1.53 Million50%
1993 -โ‚ฌ1.02 Million20%
1992 -โ‚ฌ0.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.13 Billion 627.71%๐Ÿ‡บ๐Ÿ‡ธ USA